Human Adrenomedullin Gene Delivery Protects against Cardiac Hypertrophy, Fibrosis, and Renal Damage in Hypertensive Dahl Salt-Sensitive Rats
- 1 September 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 11 (13) , 1817-1827
- https://doi.org/10.1089/10430340050129440
Abstract
Adrenomedullin (AM) is a potent vasodilator expressed in tissues relevant to cardiac and renal functions. Our previous study showed that delivery of the human AM gene in the form of naked DNA caused a prolonged reduction of blood pressure in genetically hypertensive rats. In this study, we evaluated potential protective effects of adenovirus-mediated AM gene delivery on salt-induced cardiorenal lesions in hypertensive Dahl saltsensitive (DSS) rats. Adenovirus carrying the human AM cDNA under the control of the cytomegalovirus promoter-enhancer (Ad.CMV-hAM) was generated by homologous recombination of E. coli. Expression of recombinant human AM was detected by a radioimmunoassay in the medium of human embryonic kidney 293 cells transfected with Ad.CMV-hAM. A single intravenous injection of Ad.CMV-hAM caused a significant reduction of systolic blood pressure for 4 weeks in DSS rats compared with control rats with or without injection of adenovirus carrying the green fluorescent protein gene. AM gene delivery significantly reduced left ventricular mass and urinary protein, increased cAMP levels, and enhanced renal function as evidenced by increases in glomerular filtration rate and renal blood flow. Morphological investigations showed that AM gene transfer reduced cardiomyocyte diameter and interstitial fibrosis in the heart as well as glomerular sclerosis, tubular disruption, and protein cast accumulation in the kidney. Expression of human AM mRNA was identified in rat heart, kidney, lung, liver, and aorta, and immunoreactive human AM levels were measured in rat plasma and urine. These results indicate that human AM gene delivery protects against salt-induced hypertension and cardiac and renal lesions in DSS rats via activation of cAMP as a second messenger. These findings provide new insights into the role of AM in salt-induced hypertension and may have implications in therapeutic applications to salt-related cardiovascular and renal diseases.Keywords
This publication has 36 references indexed in Scilit:
- Brief Report: Liver Bypass Significantly Increases the Transduction Efficiency of Recombinant Adenoviral Vectors in the Lung, Intestine, and KidneyHuman Gene Therapy, 2000
- Adenovirus-Mediated Kallikrein Gene Delivery Reduces Aortic Thickening and Stroke-Induced Death Rate in Dahl Salt-Sensitive RatsStroke, 1999
- Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in ratsKidney International, 1998
- Adrenomedullin: Changes in Circulating and Cardiac Tissue Concentration in Dahl Salt-Sensitive Rats on a High-Salt DietClinical and Experimental Hypertension, 1996
- Adrenomedullin Suppresses Mitogenesis in Rat Mesangial Cells via cAMP PathwayBiochemical and Biophysical Research Communications, 1995
- Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasmaFEBS Letters, 1994
- Human tissue kallikrein induces hypotension in transgenic mice.Hypertension, 1994
- TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathyKidney International, 1994
- Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasmaFEBS Letters, 1994
- Early interstitial changes in hypertension-induced renal injury.Hypertension, 1993